PL02.18 Phase 3 Trial of Crizotinib vs Observation for Surgically Resected Early-Stage ALK+ NSCLC
作者
David E. Gerber,Y. Wang,Corey J. Langer,Onkar V. Khullar,D.E. Kozono,Lynn A. Cornelius,Patrick M. Forde,matthew Obinna nwaneri,Joel W. Neal,Ashita D. Talsania,Ticiana Leal,Minal Patel,Kavitha Donthireddy,S.N. Waqar,Jamie E. Chaft,Ramaswamy Govindan,Jacob Sands,Shakun Malik,Tianhong Li,Thomas E. Stinchcombe